Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Merck
Covington
Boehringer Ingelheim
Cerilliant
Chinese Patent Office
Argus Health
Mallinckrodt
Fish and Richardson
QuintilesIMS

Generated: December 12, 2017

DrugPatentWatch Database Preview

Insys Dev Co Inc Company Profile

« Back to Dashboard

What is the competitive landscape for INSYS DEV CO INC, and when can generic versions of INSYS DEV CO INC drugs launch?

INSYS DEV CO INC has two approved drugs.

There are ten US patents protecting INSYS DEV CO INC drugs and there have been three Paragraph IV challenges on INSYS DEV CO INC drugs in the past three years.

There are twenty-six patent family members on INSYS DEV CO INC drugs in fifteen countries and ten supplementary protection certificates in four countries.

Summary for Insys Dev Co Inc

International Patents:26
US Patents:10
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-007Aug 30, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-001Jan 4, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-003Jan 4, 2012RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-006Aug 30, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-007Aug 30, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-004Jan 4, 2012RXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Insys Dev Co IncSYNDROSdronabinolSOLUTION;ORAL205525-001Mar 23, 2017RXYesYes► Subscribe► Subscribe► SubscribeYY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-006Aug 30, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-004Jan 4, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
Insys Dev Co IncSUBSYSfentanylSPRAY;SUBLINGUAL202788-006Aug 30, 2012RXYesNo► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for INSYS DEV CO INC drugs

Drugname Dosage Strength Tradename Submissiondate
fentanylSublingual Spray0.4 mg/spraySUBSYS5/22/2017
dronabinolOral Solution5mg/mlSYNDROS4/17/2017
dronabinolOral solution5 mg/mLSYNDROS4/17/2017

International Patent Family for Insys Dev Co Inc Drugs

Country Document Number Estimated Expiration
Japan5630877► Subscribe
Canada2698749► Subscribe
European Patent Office2184983► Subscribe
Russian Federation2432950► Subscribe
Russian Federation2008130763► Subscribe
Japan2010535774► Subscribe
Slovenia1976521► Subscribe
Australia2008282743► Subscribe
Denmark1976521► Subscribe
Japan5241514► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Insys Dev Co Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2014 00016Denmark► SubscribePRODUCT NAME: FENTANYL I EN HVILKEN SOM HELST AF DE FORMER, DER ER BESKYTTET AF GRUNDPATENTET; REG. NO/DATE: EU/1/10/644/001-006 20100831
00523Netherlands► SubscribePRODUCT NAME: FENTANYL; REGISTRATION NO/DATE: EU/2/11/127/001 20111006
0653Netherlands► SubscribePRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906
00522Netherlands► SubscribePRODUCT NAME: FENTANYL EN DOSERINGSAPPLICATOR; REG. NO/DATE: EU/2/11/127/001 20111006
C/GB06/022United Kingdom► SubscribePRODUCT NAME: FENTANYL HYDROCHLORIDE; REGISTERED: UK EU/1/05/326/001 20060124
00521Netherlands► SubscribePRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006
2006000022Germany► SubscribePRODUCT NAME: TRANSDERMAL IONTOPHORETISCH VERABREICHTES FENTANYL-HYDROCHLORID; REGISTRATION NO/DATE: EU/1/05/326/001 20060126
2011000009Germany► SubscribePRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
00653Netherlands► SubscribePRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906
2014000024Germany► SubscribePRODUCT NAME: FENTANYL IN ALLEN DEM SCHUTZ DES GRUNDPATENTS UNTERLIEGENDEN FORMEN; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100831
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Cipla
Accenture
Boehringer Ingelheim
Chinese Patent Office
Moodys
Fuji
McKinsey
UBS
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot